President Donald Trump speaks speaks on the latest developments of the coronavirus outbreak, while flanked by White House coronavirus response coordinator Debbie Birx (L), and U.S. Surgeon General Jerome Adams (R), in the James Brady Press Briefing Room at the White House March 19, 2020. (Photo by Chip Somodevilla/Getty Images)
President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
Tearfully embracing a history-making moment, Judge Ketanji Brown Jackson said Friday her confirmation as the first Black woman to the Supreme Court showed the progress of America.
Krutika Amin, associate director at the Kaiser Family Foundation for the Program on the Affordable Care Act, joins Cheddar Politics to discuss the Biden administration's plan to fix the so-called 'family glitch' in the Affordable Care Act preventing millions of Americans from accessing government-subsidized health plan.
Abdallah Fayyad, opinion writer at the Boston Globe, joins Cheddar Politics to discuss the House's vote to hold former Trump aides Dan Scavino and Peter Navarro in contempt of Congress and send the recommendation to the Department of Justice. Fayyad also weighs in on the pressure facing Attorney General Merrick Garland to be more aggressive in prosecuting the January 6 case.
Those paying back federal student loans are getting a few extra months of relief. President Biden just announced another extension of the pandemic relief program allowing millions of borrowers to freeze their student loan payments. The pause began in March 2020 and it has been extended six times. Tomas Campos, co-founder and CEO of Spinwheel, joins Cheddar News to discuss.
There has been notable disagreement in the medical community about a fourth COVID-19 vaccine dose. The FDA last week authorized a second booster dose for older and immunocompromised individuals, as some agency officials did not support the idea. The FDA made the decision without meeting with its advisory committee, as it had ahead of its recommendations on the previous COVID-19 vaccine doses.
The CDC followed in the footsteps of the FDA and authorized a fourth dose as well. Reports say the agency also did not discuss the move with its own advisory team of vaccine experts. Now, a growing number of doctors are speaking out against the decisions - leaving people confused about whether they should get another vaccine dose. Dr. Julie Morita, a member of the CDC's advisory committee to the director, and the executive vice president of the Robert Wood Johnson Foundation, joins Cheddar News' Closing Bell to discuss.
The Senate has confirmed Ketanji Brown Jackson to the Supreme Court, shattering a historic barrier by securing her place as the first Black female justice and giving President Joe Biden a bipartisan endorsement for his effort to diversify the court
House Speaker Nancy Pelosi has tested positive for COVID-19, her spokesman says. That's a day after the 82-year-old Democratic leader appeared unmasked at a White House event with President Joe Biden.